Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Arias

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
European Journal of Heart Failure|September 28, 2020
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trialsJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
The New England Journal of Medicine|August 22, 2019
Effects of Serelaxin in Patients with Acute Heart FailureMarco Metra, John R Teerlink, Gad Cotter, et al.
The New England Journal of Medicine|November 13, 2020
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
Acta Neuropathologica|August 21, 2019
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational programMaxime Janin, Vanessa Ortiz-Barahona, Manuel Castro de Moura, et al.
American Heart Journal|June 25, 2026
THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATIONBalimkiz Senman, P Elliott Miller, Ann Gage, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
European Journal of Heart Failure|September 28, 2020
Omecamtiv mecarbil in chronic heart failure with reduced ejection fraction: GALACTIC-HF baseline characteristics and comparison with contemporary clinical trialsJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
The New England Journal of Medicine|August 22, 2019
Effects of Serelaxin in Patients with Acute Heart FailureMarco Metra, John R Teerlink, Gad Cotter, et al.
The New England Journal of Medicine|November 13, 2020
Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart FailureJohn R Teerlink, Rafael Diaz, G Michael Felker, et al.
Acta Neuropathologica|August 21, 2019
Epigenetic loss of RNA-methyltransferase NSUN5 in glioma targets ribosomes to drive a stress adaptive translational programMaxime Janin, Vanessa Ortiz-Barahona, Manuel Castro de Moura, et al.
American Heart Journal|June 25, 2026
THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATIONBalimkiz Senman, P Elliott Miller, Ann Gage, et al.
Pageof 13